ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer

ClinicalTrials.gov ID: NCT06282575

Public ClinicalTrials.gov record NCT06282575. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 4:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label Randomized Trial of the Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy Alone for Advanced HER2-positive Biliary Tract Cancer

Study identification

NCT ID
NCT06282575
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Jazz Pharmaceuticals
Industry
Enrollment
286 participants

Conditions and interventions

Interventions

  • Cisplatin Drug
  • Durvalumab Drug
  • Gemcitabine Drug
  • Pembrolizumab Drug
  • Zanidatamab Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 18, 2024
Primary completion
Nov 30, 2028
Completion
Mar 31, 2030
Last update posted
Mar 23, 2026

2024 – 2030

United States locations

U.S. sites
21
U.S. states
17
U.S. cities
19
Facility City State ZIP Site status
City of Hope(City of Hope National Medical Center, City of Hope Medical Center) Duarte California 91010 Recruiting
Rocky Mountain Cancer Centers, LLP Lone Tree Colorado 80124 Active, not recruiting
AdventHealth Hematology and Oncology Orlando Florida 32804 Recruiting
Winship Cancer Institute Atlanta Georgia 30322 Recruiting
The University of Kansas Cancer Center - Westwood Westwood Kansas 66205 Active, not recruiting
Norton Cancer Institute - Audubon Louisville Kentucky 40217 Recruiting
Ochsner Clinic Foundation New Orleans Louisiana 70121 Recruiting
Tufts Medical Center Boston Massachusetts 02111 Active, not recruiting
University of Michigan Hospital Ann Arbor Michigan 48109 Recruiting
Henry Ford Health System Detroit Michigan 48202 Recruiting
Minnesota Oncology Hematology, P.A. Maple Grove Minnesota 55369 Active, not recruiting
Atlantic Health System/Morristown Medical Center Morristown New Jersey 07960 Active, not recruiting
Laura and Isaac Perlmutter Cancer Center at NYU Langone - Ambulatory Care Center New York New York 10016 Recruiting
Memorial Sloan Kettering Cancer Centers New York New York 10022 Recruiting
Oregon Health and Science University Portland Oregon 97239 Recruiting
Saint Francis Cancer Center Greenville South Carolina 29607 Recruiting
SCRI Oncology Partners Nashville Tennessee 37203 Active, not recruiting
Texas Oncology - DFW Dallas Texas 75246 Active, not recruiting
University of Texas Southwestern Medical Center Dallas Texas 75390 Recruiting
The Univerrsity of Texas MD Anderson Cancer Center Houston Texas 77030 Recruiting
Virginia Commonwealth University, VCU Health Richmond Virginia 23219 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 163 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06282575, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 23, 2026 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06282575 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →